A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

Clinical trial NCT02699450 · COMPLETED

Trial details

NCT number: NCT02699450
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2016-04-27
Primary completion: 2017-09-15
Enrollment: 229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.